ClinicalTrials.gov
ClinicalTrials.gov Menu

Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01676649
Recruitment Status : Active, not recruiting
First Posted : August 31, 2012
Last Update Posted : March 1, 2017
Sponsor:
Information provided by (Responsible Party):
Wilson Miller, Jewish General Hospital